Literature DB >> 19421844

Mechanism-based pharmacokinetic-pharmacodynamic modeling of bidirectional effect of danshensu on plasma homocysteine in rats.

Yuancheng Chen1, Yanguang Cao, Jia Zhou, Xiaoquan Liu.   

Abstract

PURPOSE: To develop a mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) model to characterize and predict the bidirectional effect of danshensu on plasma total homocysteine (tHcy) in rats described in our previous paper.
METHODS: The effect of danshensu on tHcy was assessed in rats after simultaneously methionine loading. Danshensu, its methylated metabolite and tHcy were all quantified after single intravenous injection of 20 mg/kg danshensu. The bidirectional effect, of which, elevated by danshensu methylation and decreased via transsulfuration promotion, was characterized by a PK-PD model, where direct stimulatory sigmoidal function and time-dependent transduction function were introduced for the two effects description, respectively.
RESULTS: Modeling and simulations reveals that: (1) the elevated effect by methylation occurs before the decreased effect via transsulfuration promotion, and the decreased effect is more profoundly dose-dependent than the elevated effect; (2) two steps are simplified to describe the delayed stimulatory effect on the transsulfuration in the model; (3) long term administration of danshensu dose not affect tHcy in normal rats, while it significantly reduces tHcy in rats treated with methionine. This is in consistent with previous report.
CONCLUSIONS: The profiles were well-described by our PK-PD model, which constitutes a basis for the future development of mechanism-based model for polyphenols on Hcy in this paradigm.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19421844     DOI: 10.1007/s11095-009-9899-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

1.  Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena.

Authors:  A Sharma; W F Ebling; W J Jusko
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

2.  Plasma homocysteine levels and mortality in patients with coronary artery disease.

Authors:  O Nygård; J E Nordrehaug; H Refsum; P M Ueland; M Farstad; S E Vollset
Journal:  N Engl J Med       Date:  1997-07-24       Impact factor: 91.245

3.  Lifestyle factors and plasma homocysteine concentrations in a general population sample.

Authors:  A de Bree ; W M Verschuren; H J Blom; D Kromhout
Journal:  Am J Epidemiol       Date:  2001-07-15       Impact factor: 4.897

4.  Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers.

Authors:  A Yassen; E Olofsen; R Romberg; E Sarton; L Teppema; M Danhof; A Dahan
Journal:  Clin Pharmacol Ther       Date:  2007-01       Impact factor: 6.875

5.  Analysis of pathological defects in methionine metabolism using a simple mathematical model.

Authors:  Anna Prudova; Mikhail V Martinov; Victor M Vitvitsky; Fazoil I Ataullakhanov; Ruma Banerjee
Journal:  Biochim Biophys Acta       Date:  2005-09-25

6.  Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics.

Authors:  Y N Sun; W J Jusko
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

7.  Effects of catechin on homocysteine metabolism in hyperhomocysteinemic mice.

Authors:  Julien Hamelet; Karine Demuth; Julien Dairou; Aurélie Ledru; Jean-Louis Paul; Jean-Marie Dupret; Jean-Maurice Delabar; Fernando Rodrigues-Lima; Nathalie Janel
Journal:  Biochem Biophys Res Commun       Date:  2007-02-02       Impact factor: 3.575

8.  Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction.

Authors:  K Chan; S H Chui; D Y L Wong; W Y Ha; C L Chan; R N S Wong
Journal:  Life Sci       Date:  2004-11-12       Impact factor: 5.037

9.  Simultaneous determination of danshensu, ferulic acid, cryptotanshinone and tanshinone IIA in rabbit plasma by HPLC and their pharmacokinetic application in danxiongfang.

Authors:  Xiaoli Li; Xiaorong Li; Lijuan Wang; Yuhang Li; Yanxia Xu; Ming Xue
Journal:  J Pharm Biomed Anal       Date:  2007-05-03       Impact factor: 3.935

10.  Therapeutical approach to plasma homocysteine and cardiovascular risk reduction.

Authors:  Marcello Ciaccio; Giulia Bivona; Chiara Bellia
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

View more
  5 in total

1.  Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an In Vitro Pharmacokinetic/Pharmacodynamic Model.

Authors:  Xingchen Bian; Xiaofen Liu; Yuancheng Chen; Daijie Chen; Jian Li; Jing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells.

Authors:  Jingwei Zhang; Fang Zhou; Xiaolan Wu; Xiaoxuan Zhang; Yuancheng Chen; Beth S Zha; Fang Niu; Meng Lu; Gang Hao; Yuan Sun; Jianguo Sun; Ying Peng; Guangji Wang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

3.  Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against Acinetobacter baumannii in Patients with Hospital-Acquired Pneumonia.

Authors:  Yingjie Zhou; Jing Zhang; Yuancheng Chen; Jufang Wu; Beining Guo; Xiaojie Wu; Yingyuan Zhang; Minggui Wang; Ru Ya; Hao Huang
Journal:  Antibiotics (Basel)       Date:  2022-05-23

4.  Modeling Disease Progression: Angiotensin II Indirectly Inhibits Nitric Oxide Production via ADMA Accumulation in Spontaneously Hypertensive Rats.

Authors:  Haidong Wang; Hao Jiang; Haochen Liu; Xue Zhang; Guimei Ran; Hua He; Xiaoquan Liu
Journal:  Front Physiol       Date:  2016-11-17       Impact factor: 4.566

5.  The pharmacokinetic-pharmacodynamic model of azithromycin for lipopolysaccharide-induced depressive-like behavior in mice.

Authors:  Kun Hao; Qu Qi; Haiping Hao; Guangji Wang; Yuancheng Chen; Yan Liang; Lin Xie
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.